Treatment patterns and outcomes with luspatercept in patients with lower-risk myelodysplastic syndromes: A retrospective US cohort analysis

Hemasphere. 2024 Jan 30;8(1):e38. doi: 10.1002/hem3.38. eCollection 2024 Jan.

Authors

Sudipto Mukherjee¹, Cherrishe Brown-Bickerstaff², Angelica Falkenstein², Adeola Y Makinde³, Emily Bland⁴, JaLyna Laney⁴, Marné Garretson², David Huggar³, Ali McBride³

Affiliations

¹ Department of Hematology and Medical Oncology Taussig Cancer Institute, Cleveland Clinic Cleveland Ohio USA.
² Formerly of Cardinal Health Dublin Ohio USA.
³ Bristol Myers Squibb Princeton New Jersey USA.
⁴ Cardinal Health Dublin Ohio USA.

No abstract available